Publications du CNR en 2011

Ali, M. A., Bastian, S., Ismail, R., Choon, T. S., Ali, S., Aubry, A., Pandian, S., Saraswat, P., Singh, A. and Gaur, R. (2011). Discovery of novel methanone derivatives acting as antimycobacterial agents. Journal of Enzyme Inhibition and Medicinal Chemistry 26, 890–894,
Antoun, F. and Veziris, N. (2011). Gestion des tuberculoses multirésistantes. Revue des Maladies Respiratoires 28, 956–957,
Bastian, S., Veziris, N., Roux, A.-L., Brossier, F., Gaillard, J.-L., Jarlier, V. and Cambau, E. (2011). Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing. Antimicrob Agents Chemother 55, 775–781,
Bouakaze, C., Keyser, C., Gonzalez, A., Sougakoff, W., Veziris, N., Dabernat, H., Jaulhac, B. and Ludes, B. (2011). Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Single Nucleotide Polymorphism Genotyping Assay Using iPLEX Gold Technology for Identification of Mycobacterium tuberculosis Complex Species and Lineages. J Clin Microbiol 49, 3292–3299,
Brossier, F. (2011). Mécanismes d’action et de résistance de l’isoniazide, un antituberculeux de première ligne. Journal des Anti-Infectieux 13, 217–227,
Brossier, F., Veziris, N., Truffot-Pernot, C., Jarlier, V. and Sougakoff, W. (2011). Molecular Investigation of Resistance to the Antituberculous Drug Ethionamide in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 55, 355–360,
Cambau, E. and Rüsch-Gerdes, S. (2011). First- and second-line drug susceptibility testing for Mycobacterium tuberculosis complex, ECDC, Stockholm, URL:
Couderc, C., Carbonne, A., Thiolet, J. M., Brossier, F., Savey, A., Bernet, C., Ortmans, C., Lecadet-Morin, C., Coudière, I., Aggoune, M., Astagneau, P., Coignard, B. and Cambau, E. (2011). Infections à mycobactéries atypiques liées à des soins esthétiques en France, 2001–2010. Médecine et Maladies Infectieuses 41, 379–383,
Cribier, B., Aubry, A., Caumes, E., Cambau, E., Jarlier, V. and Chosidow, O. (2011). [Histopathological study of Mycobacterium marinum infection]. Ann Dermatol Venereol 138, 17–22,
Fauville-Dufaux, M., Jarlier, V., van Soolingen, D. and Hoffner, S. (2011). Biosafety in the clinical laboratory diagnosis of tuberculosis. In: Mastering the basics of TB control - Development of a handbook on TB diagnostic methods, ECDC, Stockholm, pp. 11–18, URL: doi 10.2900/39099.
Lerat, I., Truffot, C. and Veziris, N. (2011). Infections à Mycobacterium abscessus : épidémiologie, aspects cliniques et traitement. Journal des Anti-infectieux 13, 49–55.
Macheras, E., Roux, A.-L., Bastian, S., Leão, S. C., Palaci, M., Sivadon-Tardy, V., Gutierrez, C., Richter, E., Rüsch-Gerdes, S., Pfyffer, G., Bodmer, T., Cambau, E., Gaillard, J.-L. and Heym, B. (2011). Multilocus Sequence Analysis and rpoB Sequencing of Mycobacterium abscessus (Sensu Lato) Strains. J Clin Microbiol 49, 491–499,
Pantel, A., Petrella, S., Matrat, S., Brossier, F., Bastian, S., Reitter, D., Jarlier, V., Mayer, C. and Aubry, A. (2011). DNA Gyrase Inhibition Assays Are Necessary To Demonstrate Fluoroquinolone Resistance Secondary to gyrB Mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother 55, 4524–4529,
Petrella, S., Gelus-Ziental, N., Maudry, A., Laurans, C., Boudjelloul, R. and Sougakoff, W. (2011). Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis : Insights into Natural and Acquired Resistance to Pyrazinamide. PLOS ONE 6, e15785,
Prevotat, A., Bonne, S., Veziris, N., Senneville, E., Yazdanpanah, Y. and Legout, L. (2011). [Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient]. Med Mal Infect 41, 446–448,
Radomski, N., Betelli, L., Moilleron, R., Haenn, S., Moulin, L., Cambau, E., Rocher, V., Gonçalves, A. and Lucas, F. S. (2011). Mycobacterium Behavior in Wastewater Treatment Plant, A Bacterial Model Distinct From Escherichia coli and Enterococci. Environ Sci Technol 45, 5380–5386,
Schneider, P., Monsel, G., Veziris, N., Roujeau, J.-C., Bricaire, F. and Caumes, E. (2011). Successful treatment of nodular lymphangitis due to in two immunosuppressed patients. Dermatology Online Journal 17, URL: [Accessed September 2013].
Sougakoff, W. (2011). Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis. Clinical Microbiology and Infection 17, 800–805,
Tochon, M., Bosdure, E., Salles, M., Beloncle, C., Chadelat, K., Dagorne, M., Gaudelus, J., Losi, S., Renoux, M. C., Veziris, N. and Dubus, J. C. (2011). Management of young children in contact with an adult with drug-resistant tuberculosis, France, 2004-2008. Int J Tuberc Lung Dis 15, 326–330.
Truffot-Pernot, C. and Veziris, N. (2011). Les tests bactériologiques de la tuberculose maladie : standards et perspectives. Revue des Maladies Respiratoires 28, 1034–1047,
van Soolingen, D., Jarlier, V. and Drobniewski, F. (2011). Information for physicians: the laboratory diagnosis of tuberculosis – first steps. In: Mastering the basics of TB control - Development of a handbook on TB diagnostic methods, ECDC, Stockholm, pp. 96–99, URL: doi 10.2900/39099.
Veziris, N., Truffot, C., Mainardi, J.-L. and Jarlier, V. (2011). Activity of carbapenems combined with clavulanate in murine tuberculosis. Antimicrob Agents Chemother,
Veziris, N., Ibrahim, M., Lounis, N., Andries, K. and Jarlier, V. (2011). Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis. PLoS ONE 6, e17556,